Earnings Feed
Start Free
Home/Filings/4/0001855763-21-000023
4//SEC Filing

Downey Gregory 4

Accession 0001855763-21-000023

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 1:19 PM ET

Size

11.8 KB

Accession

0001855763-21-000023

Insider Transaction Report

Form 4
Period: 2021-09-01
Lexaria Bioscience Corp.LEXX
Downey Gregory
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2021-09-01+10,000→ 35,000 total
    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
Holdings

  • common shares

    1,833

  • Stock Options

    Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    4,000

  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (8,000 underlying)
    25,000

  • Stock Options

    Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)
    17,000

  • Stock Options

    Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    8,000

  • Stock Options

    Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    12,000

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001855801

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 1:19 PM ET
Size
11.8 KB
View on SEC.gov